News headlines about Henry Schein (NASDAQ:HSIC) have been trending somewhat positive on Saturday, Accern Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Henry Schein earned a news impact score of 0.18 on Accern’s scale. Accern also gave media stories about the company an impact score of 47.4121242186576 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.
Here are some of the news stories that may have effected Accern Sentiment’s rankings:
- Henry Schein Disaster Relief Hotline Is Open To Support Customers Affected By Hurricane Harvey (finance.yahoo.com)
- Henry Schein, Inc. to Post Q3 2017 Earnings of $1.80 Per Share, Jefferies Group Forecasts (HSIC) (americanbankingnews.com)
- Henry Schein, Inc. to Post Q4 2017 Earnings of $1.97 Per Share, Jefferies Group Forecasts (HSIC) (americanbankingnews.com)
- Henry Schein To Present At Two Conferences In September (finance.yahoo.com)
- Henry Schein, Inc. (HSIC) Expected to Announce Quarterly Sales of $3.05 Billion (americanbankingnews.com)
Shares of Henry Schein (NASDAQ HSIC) traded up 0.30% during mid-day trading on Friday, hitting $171.57. The stock had a trading volume of 484,033 shares. The firm has a market capitalization of $13.56 billion, a price-to-earnings ratio of 25.07 and a beta of 1.09. The stock’s 50-day moving average is $177.99 and its 200 day moving average is $175.84. Henry Schein has a 1-year low of $146.23 and a 1-year high of $186.99. Shares of Henry Schein are going to split before the market opens on Friday, September 15th. The 2-1 split was announced on Wednesday, August 16th. The newly minted shares will be distributed to shareholders after the market closes on Thursday, September 14th.
Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, August 8th. The company reported $1.75 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.73 by $0.02. The firm had revenue of $3.06 billion for the quarter, compared to analyst estimates of $3.05 billion. Henry Schein had a return on equity of 19.91% and a net margin of 4.59%. The company’s revenue was up 6.4% on a year-over-year basis. During the same quarter last year, the firm posted $1.64 EPS. Equities research analysts predict that Henry Schein will post $7.27 EPS for the current fiscal year.
A number of analysts have weighed in on the company. Zacks Investment Research downgraded Henry Schein from a “buy” rating to a “hold” rating in a report on Wednesday, August 9th. Northcoast Research upgraded Henry Schein from a “neutral” rating to a “buy” rating and set a $218.00 price target for the company in a report on Monday, August 7th. BidaskClub downgraded Henry Schein from a “hold” rating to a “sell” rating in a report on Wednesday, August 2nd. Credit Suisse Group reiterated a “hold” rating and set a $160.00 price target on shares of Henry Schein in a report on Thursday, July 13th. Finally, Barrington Research increased their price target on Henry Schein from $196.00 to $198.00 and gave the stock an “outperform” rating in a report on Wednesday, May 10th. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and seven have issued a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $185.56.
ILLEGAL ACTIVITY WARNING: This piece of content was reported by StockNewsTimes and is the property of of StockNewsTimes. If you are accessing this piece of content on another site, it was illegally stolen and republished in violation of US and international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://stocknewstimes.com/2017/08/27/henry-schein-hsic-receiving-somewhat-positive-press-coverage-report-finds.html.
Henry Schein Company Profile
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
